Enanta Pharmaceuticals
ENTA
#8720
Rank
C$0.31 B
Marketcap
C$10.92
Share price
-4.51%
Change (1 day)
-35.88%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2026 (TTM): C-$3.36

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$3.45. In 2025 the company made an earnings per share (EPS) of C-$4.59 an increase over its 2024 EPS that were of C-$7.09.

EPS history for Enanta Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$3.36-26.66%
2025C-$4.59-35.35%
2024C-$7.09
2021C-$7.1472.92%
2020C-$4.13-267.44%
2019C$2.47-61.35%
2018C$6.38147.22%
2017C$2.58-460%
2016C-$0.72-114.88%
2015C$4.82-23.81%
2014C$6.32-244.12%
2013C-$4.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57-377.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.52-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$8.39-342.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$22.46-750.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.48-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA